164 related articles for article (PubMed ID: 13679447)
1. p53 alterations and their relationship to SDHD mutations in parasympathetic paragangliomas.
van Nederveen FH; Dannenberg H; Sleddens HF; de Krijger RR; Dinjens WN
Mod Pathol; 2003 Sep; 16(9):849-56. PubMed ID: 13679447
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
4. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
5. Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma.
Dannenberg H; Dinjens WN; Abbou M; Van Urk H; Pauw BK; Mouwen D; Mooi WJ; de Krijger RR
Clin Cancer Res; 2002 Jul; 8(7):2061-6. PubMed ID: 12114404
[TBL] [Abstract][Full Text] [Related]
6. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
8. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
9. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
10. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
11. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
13. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
[TBL] [Abstract][Full Text] [Related]
14. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
[TBL] [Abstract][Full Text] [Related]
15. Mutations associated with succinate dehydrogenase D-related malignant paragangliomas.
Timmers HJ; Pacak K; Bertherat J; Lenders JW; Duet M; Eisenhofer G; Stratakis CA; Niccoli-Sire P; Tran BH; Burnichon N; Gimenez-Roqueplo AP
Clin Endocrinol (Oxf); 2008 Apr; 68(4):561-6. PubMed ID: 17973943
[TBL] [Abstract][Full Text] [Related]
16. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
17. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
[TBL] [Abstract][Full Text] [Related]
18. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
McWhinney SR; Pilarski RT; Forrester SR; Schneider MC; Sarquis MM; Dias EP; Eng C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5694-9. PubMed ID: 15531530
[TBL] [Abstract][Full Text] [Related]
19. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.
Gimenez-Roqueplo AP; Favier J; Rustin P; Mourad JJ; Plouin PF; Corvol P; Rötig A; Jeunemaitre X
Am J Hum Genet; 2001 Dec; 69(6):1186-97. PubMed ID: 11605159
[TBL] [Abstract][Full Text] [Related]
20. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.
Taschner PE; Jansen JC; Baysal BE; Bosch A; Rosenberg EH; Bröcker-Vriends AH; van Der Mey AG; van Ommen GJ; Cornelisse CJ; Devilee P
Genes Chromosomes Cancer; 2001 Jul; 31(3):274-81. PubMed ID: 11391798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]